您的位置：山东大学 -> 科技期刊社 -> 《山东大学学报（医学版）》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (2): 41-47.doi: 10.6040/j.issn.1671-7554.0.2020.1628

• 临床医学 • 上一篇    下一篇

低氧诱导因子-1α在子宫内膜异位症患者血清中的表达和对在位子宫内膜间质细胞上皮-间质转化的影响

薛源1,林雪艳2,徐歌1,田永杰1   

  1. 1.山东大学附属省立医院妇产科, 山东 济南 250021;2.山东第一医科大学附属省立医院妇产科, 山东 济南 250021
  • 发布日期:2021-03-05
  • 通讯作者: 田永杰. E-mail:tianyongjie@sdu.edu.cn
  • 基金资助:
    山东省自然科学基金(ZR2019MH129)

Expression of hypoxia-inducible factor-1α in the serum of patients with endometriosis and its effect on epithelial mesenchymal transition of eutopic endometrial stromal cells

XUE Yuan1, LIN Xueyan2, XU Ge1, TIAN Yongjie1   

  1. 1. Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250021, Shandong, China;
    2. Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2021-03-05

PDF (PC)

153

摘要： 目的 研究低氧诱导因子-1α(HIF-1α)在子宫内膜异位症(EMS)患者血清中的表达水平及诊断价值,探讨HIF-1α对EMS在位子宫内膜间质细胞上皮-间质转化(EMT)的影响。 方法 采用ELISA法对EMS(36例,EMS组)和子宫肌瘤(43例,对照组)患者血清的HIF-1α水平进行测量分析,其中EMS组患者临床分期I期、Ⅱ期为EMS轻度组,Ⅲ期、Ⅳ期为EMS重度组。采用受试者工作特征(ROC)曲线以及曲线下面积(AUC)反应HIF-1α的诊断水平。取EMS在位子宫内膜分离培养提取原代间质细胞,干扰HIF-1α表达的慢病毒和空白病毒分别转染该细胞,得到sh-HIF-1α和sh-NC两组细胞,采用Western blotting法测量EMT相关分子(N-Cadherin、vimentin、Slug)的表达;Transwell法对比两组细胞的迁移、侵袭能力;流式细胞术检测两组细胞的凋亡率。 结果 EMS组与对照组比较,其血清HIF-1α表达水平明显增高(P<0.001);其ROC曲线及AUC结果显示HIF-1α对EMS具有一定的诊断效力,子宫内膜增生期与分泌期所对应的血清HIF-1α表达差异无统计学意义(P=0.593),EMS重度组患者血清HIF-1α含量显著高于EMS轻度组(P<0.001)。sh-HIF-1α组细胞的N-Cadherin(P=0.013)、vimentin(P=0.045)、Slug(P=0.038)表达均降低,细胞迁移、侵袭力减弱(P均<0.001),凋亡率升高(P=0.013)。 结论 HIF-1α在EMS患者血清中表达水平明显升高,可作为一项潜在的临床诊断指标;HIF-1α可能通过调控EMT过程影响EMS的发生发展。

关键词: 子宫内膜异位症, 低氧诱导因子-1α, 上皮-间质转化, 迁移、侵袭, 细胞凋亡

Abstract: Objective To explore the expression level and diagnostic value of hypoxia-inducible factor-1α(HIF-1α)in the serum of patients with endometriosis(EMS), and to investigate the effect of HIF-1α on epithelial mesenchymal transition(EMT)of eutopic endometrial stromal cells in EMS. Methods The serum HIF-1α levels in 36 EMS cases(EMS group)and 43 uterine leiomyoma cases(control group)were determined with ELISA. In the EMS group, patients with clinical stages I and II were classified as mild cases and those with stages Ⅲ and Ⅳ were classified as severe cases. The diagnostic value of HIF-1α was calculated with the receiver operating characteristic(ROC)curve and the area under the curve(AUC). Primary endometrial stromal cells were isolated and cultured from eutopic endometrium with EMS. Sh-HIF-1α and sh-NC cells were transfected with lentivirus and blank virus respectively. The expressions of N-cadherin, vimentin and Slug were detected with Western blotting. The migration and invasion were detected with Transwell assay, and the apoptosis was determined with Flow cytometry. Results The EMS group had elevated serum HIF-1α (P<0.001). The ROC curve and AUC suggested that HIF-1α had certain diagnostic efficacy on EMS. There was no significant difference in the expression of HIF-1α between endometrial proliferative phase and secretory phase(P=0.593). The serum HIF-1α level in severe EMS cases was significantly higher than that in mild EMS cases(P<0.001). In sh-HIF-1α group, the expressions of N-cadherin(P=0.013), vimentin(P=0.045)and Slug(P=0.038)decreased, cell migration and invasion reduced(P<0.001), while the apoptosis rate increased(P=0.013). Conclusion HIF-1α is highly expressed in EMS patients, which can be used as a potential clinical diagnostic index. HIF-1α may affect the development of endometriosis by regulating EMT.

Key words: Endometriosis, Hypoxia inducible factor-1α, Epithelial mesenchymal transition, Migration and invasion, Apoptosis

中图分类号: 

  • R711.71
[1] 郎景和. 对子宫内膜异位症认识的历史、现状与发展[J]. 中国实用妇科与产科杂志, 2020, 36(3): 193-196.
[2] Song WW, Gui AP, Li W, et al. Expressions of HIF-1α and KISS-1 in patients with liver cancer and correlation analysis[J]. Eur Rev Med Pharmacol Sci, 2017, 21(18): 4058-4063.
[3] Chen L, Shi Y, Yuan J, et al. HIF-1 alpha overexpression correlates with poor overall survival and disease-free survival in gastric cancer patients post-gastrectomy[J]. PLoS ONE, 2014, 9(3): e90678. doi: 10.1371/journal.pone.0090678.
[4] Mansour RN, Enderami SE, Ardeshirylajimi A, et al. Evaluation of hypoxia inducible factor-1 alpha gene expression in colorectal cancer stages of Iranian patients[J]. J Canc Res Ther, 2016, 12(4): 1313-1317.
[5] Mccluggage WG. Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions: Endometriosis-related pathology[J]. Histopathology, 2020, 76(1): 76-92.
[6] Moradi M, Parker M, Sneddon A, et al. The endometriosis impact questionnaire(EIQ): a tool to measure the long-term impact of endometriosis on different aspects of womens lives[J]. BMC Womens Health, 2019, 19(1): 64. doi: 10.1186/s12905-019-0762-x.
[7] Yovich JL, Rowlands PK, Lingham S, et al. Pathogenesis of endometriosis: look no further than John Sampson[J]. Reprod Biomed Online, 2020, 40(1): 7-11.
[8] Tavcar J, Loring M, Movilla PR, et al. Diagnosing endometriosis before laparoscopy: radiologic tools to evaluate the disease[J]. Curr Opin Obstet Gynecol, 2020, 32(4): 292-297.
[9] Zhan L, Wang W, Zhang Y, et al. Hypoxia-inducible factor-1alpha: a promising therapeutic target in endometriosis[J]. Biochimie, 2016, 123(4): 130-137.
[10] Asby DJ, Cuda F, Hoakwie F, et al. HIF-1 promotes the expression of its α-subunit via an epigenetically regulated transactivation loop[J]. Mol Biosyst, 2014, 10(10): 2505-2508.
[11] Karakus S, Sancakdar E, Akkar O, et al. Elevated serum CD95/FAS and HIF-1α levels, but not Tie-2 levels, may be biomarkers in patients with severe endometriosis: a preliminary report[J]. J Minim Invasive Gynecol, 2016, 23(4): 573-577.
[12] Cai F F, Xu C, Pan X, et al. Prognostic value of plasma levels of HIF-1a and PGC-1a in breast cancer[J]. Oncotarget, 2016, 7(47): 77793-77806.
[13] Swartz JE, Pothen AJ, Stegeman I, et al. Clinical implications of hypoxia biomarker expression in head and neck squamous cell carcinoma: a systematic review[J]. Cancer Med, 2015, 4(7): 1101-1116.
[14] Jason J, Christiansen, Ayyappan K, et al. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis[J]. Cancer Res, 2006, 66(17): 8319-8326.
[15] Yang YM, Yang WX. Epithelial-to-mesenchymal transition in the development of endometriosis[J]. Oncotarget, 2017, 8(25): 41679-41689.
[16] Konrad L, Dietze R, Riaz MA, et al. Epithelial-mesenchymal transition in endometriosis—when does it happen?[J]. J Clin Med, 2020, 9(6): 1915. doi: 10.3390/jcm9061915.
[17] 周明利, 卢先州, 张树友. HIF-1α与EMT在肿瘤中的作用及意义研究进展[J]. 中国普通外科杂志, 2012, 21(9): 1132-1136. ZHOU Mingli, LU Xianzhou, ZHANG Shuyou. Role of HIF-1α and EMT in tumor progression[J]. Chinese Journal of General Surgery, 2012, 21(9): 1132-1136.
[18] Bartley J, Licher A, Hotz B, et al. Epithelial to mesenchymal transition(EMT)seems to be regulated differently in endometriosis and the endometrium[J]. Arch Gynecol Obstet, 2014, 289(4): 871-881.
[19] 林雪艳, 李春艳, 侯小满, 等. PARP-1及EMT标志物在子宫腺肌病在位及异位内膜中的表达[J]. 山东大学学报(医学版), 2017, 55(9): 36-40. LIN Xueyan, LI Chunyan, HOU Xiaoman, et al. Expression of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis[J]. Journal of Shandong University(Health Science), 2017, 55(9): 36-40.
[20] Liu CY, Lin HH, Tang MJ, et al. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation[J]. Oncotarget, 2015, 6(18): 15966-15983.
[21] Xin L, Zhao R, Lei J, et al. SND1 acts upstream of SLUG to regulate the epithelial - mesenchymal transition(EMT)in SKOV3 cells[J]. Faseb J, 2019, 33(3): 3795-3806.
[22] Li W, Zong S, Shi Q, et al. Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin[J]. Sci Rep, 2016, 6: 37534. doi: 10.1038/srep37534.
[23] Wang F, Chang M, Shi Y, et al. Down-regulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells[J]. Int J Clin Exp Med, 2014, 7(11): 3933-3940.
[24] He GD, Jiang Y, Zhang B, et al. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells[J]. Asia Pac J Clin Nutr, 2014, 23(1): 174-180.
[25] Lv F, Du R, Shang W, et al. HIF-1α silencing inhibits the growth of osteosarcoma cells by inducing apoptosis[J]. Ann Clin Lab Sci, 2016, 46(2): 140-146.
[26] Li HY, Jia YF, Wang YS, et al. Targeting HIF-1α signaling pathway for gastric cancer treatment[J]. Die Pharmazie, 2019, 74(1): 3-7.
[27] Qiu SP, Li HL, Shi HL, et al. Notoginsenoside Ft1 down-regulates HIF-1α, inhibits cell proliferation, decreases migration and promotes apoptosis in breast cancer cells[J]. Acta Pharm Sin, 2016, 51(7): 1091-1097.
[1] 鹿向东 杨伟 徐广明 曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-.
[2] 赵舸,邹存华,宋冬冬,赵淑萍. 丹参酮IIA对子宫内膜癌细胞增殖与凋亡的影响[J]. 山东大学学报 (医学版), 2022, 60(9): 53-58.
[3] 颜磊,岳彩欣,刘懿淳. 子宫内膜异位症的生育力保护[J]. 山东大学学报 (医学版), 2022, 60(9): 31-34.
[4] 冷金花,史精华. 子宫腺肌病的临床表现[J]. 山东大学学报 (医学版), 2022, 60(7): 1-5.
[5] 陈忠绍,褚然,李明宝,张向宁. MRKH综合征相关腹股沟子宫疝修补术后腹壁瘢痕子宫内膜异位症1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(5): 114-117.
[6] 林雪艳,张灿灿,田民乐,田永杰. 聚腺苷酸二磷酸核糖聚合酶-1在子宫内膜异位症中的表达及意义[J]. 山东大学学报 (医学版), 2022, 60(2): 27-31.
[7] 封海岗,刘国文,曹洪. 干扰MAD2L1基因表达对乳腺癌细胞凋亡的影响及机制[J]. 山东大学学报 (医学版), 2022, 60(10): 9-16.
[8] 单婧,王晓秋,李大金. NK细胞参与子宫内膜异位症及其不孕的分子机制[J]. 山东大学学报 (医学版), 2021, 59(8): 8-13.
[9] 卢游,且迪,伍晋辉,杨凡. 干预Sonic Hedgehog信号通路对宫内发育迟缓新生大鼠学习记忆能力的影响[J]. 山东大学学报 (医学版), 2021, 59(5): 82-89.
[10] 梁炎春,叶海花,陆丽美,戴郁菁,程谦益,蔡婉玲,曾涵秋,陈杏欢,王兴,韦雅婧,杨如玉. 慢性子宫内膜炎对子宫内膜异位症相关性不孕妊娠结局的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 55-59.
[11] 潘虹江,王焕昇,裴发军,杨明山. 孤立性膀胱子宫内膜异位症1例[J]. 山东大学学报 (医学版), 2021, 59(2): 122-124.
[12] 王国云,王凯,袁明,陈子江. 子宫内膜异位症立体化管理体系(山东方案)[J]. 山东大学学报 (医学版), 2021, 59(10): 1-16.
[13] 王宝金,赵欣欣,李霞,马倩,王新月,孙阳,史中娜. miR-203靶向Survivin抑制卵巢癌细胞增殖、迁移与侵袭[J]. 山东大学学报 (医学版), 2020, 58(12): 23-28.
[14] 史丽,马静,赵喜娃,关英霞,赵连梅,单保恩. miR-25-3p在40例子宫内膜腺癌组织中的表达及对KLE细胞生物学功能的影响[J]. 山东大学学报 (医学版), 2020, 58(12): 86-91.
[15] 张晓璐,王丽莉,陈凯明,娄宪芝,张曼. 组蛋白去乙酰化酶SIRT1经Toll样受体4途径对巨噬细胞凋亡的调控[J]. 山东大学学报 (医学版), 2020, 58(12): 8-14.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 肖伟玲,林亚杰,牟东珍,孙萍,梁淑娟 . 分泌型人IL-1β表达载体的构建及在H7402细胞中的表达[J]. 山东大学学报(医学版), 2008, 46(2): 119 -122 .
[2] 孙维彤,邹伟伟,李爱国,席延伟,张娜. 脂质体粒径对促进托氟啶口服吸收的影响[J]. 山东大学学报(医学版), 2007, 45(6): 639 -642 .
[3] 于清梅,武玉玲,宋海岩,尹华伟,庄园 . p38丝裂原活化蛋白激酶在小鼠早期胚胎及围植入期子宫内膜的表达[J]. 山东大学学报(医学版), 2008, 46(2): 123 -127 .
[4] 张勇,叶静,郭新星,肖水清. 牙周膜牵张成骨快速移动牙牙髓中IL-8表达的变化[J]. 山东大学学报(医学版), 2008, 46(4): 379 -381 .
[5] 刘益民，杜鲁涛，王丽丽，蒋秀梅，李娟，曲爱林，王海燕，郑桂喜，张欣，杨咏梅，王传新. 膀胱癌患者血清microRNA检测中内参基因的筛选及验证[J]. 山东大学学报（医学版）, 2014, 52(5): 86 -91 .
[6] 杨奎忠,孙雪飞,项继顺,杜庆聪,黄凤昌 . c-FLIP反义寡核苷酸对食管癌EC109细胞裸鼠移植瘤抑制作用的实验研究[J]. 山东大学学报(医学版), 2007, 45(12): 1234 -1238 .
[7] 俞新爽,韩俊庆,王兴文,盛巍,王瑜. 乳腺癌患者细胞免疫水平与预后危险因素的关系及临床意义[J]. 山东大学学报(医学版), 2007, 45(9): 934 -937 .
[8] 李安源,解砚英,李杰,王芃,徐淑兰,赵林 . 一服清颗粒治疗上呼吸道感染的药效学研究[J]. 山东大学学报(医学版), 2007, 45(9): 951 -954 .
[9] 高静,陈雯,张同霞,王小花,戴廷军,姚红,赵秀鹤,迟兆富,单培彦 . 颞叶癫痫大鼠海马线粒体细胞色素氧化酶亚基Ⅲ和Ⅳ表达的变化[J]. 山东大学学报(医学版), 2007, 45(8): 817 -820 .
[10] . 干细胞标记物LGR5在结直肠癌发生发展中的表达及意义[J]. 山东大学学报(医学版), 2009, 47(8): 85 -88 .
版权所有 © 2018 《山东大学学报(医学版)》编辑部　
地址:山东大学科技期刊社（济南市历城区山大南路27号山东大学中心校区明德楼B座721室） 电话: 0531-88366918 E-mail: xbyxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发